NPPA notified regarding the withdrawal of the draft notification w.r.t. M/s Sun Pharma Laboratories Ltd

Dec 02, 2025 | by TeamLease RegTech Legal Research Team

Free Legal updates for the week 00


Industry Specific ComplianceThe National Pharmaceutical Pricing Authority (NPPA) on November 27, 2025, notified regarding the withdrawal of the draft notification w.r.t. M/s Sun Pharma Laboratories Ltd.

It states that NPPA has withdrawn the draft notification issued on November 14, 2025, stating the price fixation of each uncoated bilayered tablet containing: Metformin Hydrochloride IP 500 mg (As sustained release) + myo-Inositol IP 600 mg for M/s Akums Drugs & Pharmaceuticals Ltd. (Manufacturer) & M/ Sun Pharma Laboratories Ltd. (Marketer).

[Notification no. - 19(4856)/2025/DP/NPPA/Div.II]


Bookmark

Related Updates



Alternate Text

Get updates on the go on RegUpdate Mobile App.

NEW  ·  AI ASSISTANT